Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $105.00 billion. The enterprise value is $121.87 billion.
| Market Cap | 105.00B |
| Enterprise Value | 121.87B |
Important Dates
The next estimated earnings date is Thursday, May 23, 2024, before market open.
| Earnings Date | May 23, 2024 |
| Ex-Dividend Date | Mar 21, 2024 |
Share Statistics
Medtronic has 1.33 billion shares outstanding. The number of shares has decreased by -0.02% in one year.
| Shares Outstanding | 1.33B |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 85.17% |
| Float | 1.33B |
Valuation Ratios
The trailing PE ratio is 25.18 and the forward PE ratio is 14.84. Medtronic's PEG ratio is 1.52.
| PE Ratio | 25.18 |
| Forward PE | 14.84 |
| PS Ratio | 3.25 |
| Forward PS | 3.18 |
| PB Ratio | 2.03 |
| P/FCF Ratio | 21.29 |
| PEG Ratio | 1.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.73, with an EV/FCF ratio of 24.71.
| EV / Earnings | 29.01 |
| EV / Sales | 3.77 |
| EV / EBITDA | 13.73 |
| EV / EBIT | 19.65 |
| EV / FCF | 24.71 |
Financial Position
The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.30 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 2.84 |
| Debt / FCF | 5.11 |
| Interest Coverage | 8.82 |
Financial Efficiency
Return on equity (ROE) is 8.20% and return on invested capital (ROIC) is 5.61%.
| Return on Equity (ROE) | 8.20% |
| Return on Assets (ROA) | 4.60% |
| Return on Capital (ROIC) | 5.61% |
| Revenue Per Employee | $340,211 |
| Profits Per Employee | $44,221 |
| Employee Count | 95,000 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 2.01 |
Taxes
In the past 12 months, Medtronic has paid $1.30 billion in taxes.
| Income Tax | 1.30B |
| Effective Tax Rate | 23.62% |
Stock Price Statistics
The stock price has decreased by -3.70% in the last 52 weeks. The beta is 0.78, so Medtronic's price volatility has been lower than the market average.
| Beta (1Y) | 0.78 |
| 52-Week Price Change | -3.70% |
| 50-Day Moving Average | 84.25 |
| 200-Day Moving Average | 81.79 |
| Relative Strength Index (RSI) | 30.06 |
| Average Volume (30 Days) | 6,388,575 |
Short Selling Information
The latest short interest is 12.43 million, so 0.94% of the outstanding shares have been sold short.
| Short Interest | 12.43M |
| Short Previous Month | 8.45M |
| Short % of Shares Out | 0.94% |
| Short % of Float | 0.94% |
| Short Ratio (days to cover) | 1.96 |
Income Statement
In the last 12 months, Medtronic had revenue of $32.32 billion and earned $4.20 billion in profits. Earnings per share was $3.14.
| Revenue | 32.32B |
| Gross Profit | 21.17B |
| Operating Income | 5.66B |
| Pretax Income | 5.50B |
| Net Income | 4.20B |
| EBITDA | 8.88B |
| EBIT | 6.20B |
| Earnings Per Share (EPS) | $3.14 |
Balance Sheet
The company has $8.32 billion in cash and $25.18 billion in debt, giving a net cash position of -$16.86 billion or -$12.70 per share.
| Cash & Cash Equivalents | 8.32B |
| Total Debt | 25.18B |
| Net Cash | -16.86B |
| Net Cash Per Share | -$12.70 |
| Equity / Book Value | 51.79B |
| Book Value Per Share | 39.01 |
| Working Capital | 12.72B |
Cash Flow
In the last 12 months, operating cash flow was $6.47 billion and capital expenditures -$1.54 billion, giving a free cash flow of $4.93 billion.
| Operating Cash Flow | 6.47B |
| Capital Expenditures | -1.54B |
| Free Cash Flow | 4.93B |
| FCF Per Share | $3.71 |
Margins
Gross margin is 65.50%, with operating and profit margins of 17.51% and 13.00%.
| Gross Margin | 65.50% |
| Operating Margin | 17.51% |
| Pretax Margin | 17.02% |
| Profit Margin | 13.00% |
| EBITDA Margin | 27.46% |
| EBIT Margin | 19.19% |
| FCF Margin | 15.26% |
Dividends & Yields
This stock pays an annual dividend of $2.76, which amounts to a dividend yield of 3.49%.
| Dividend Per Share | $2.76 |
| Dividend Yield | 3.49% |
| Dividend Growth (YoY) | 1.47% |
| Years of Dividend Growth | 48 |
| Payout Ratio | 87.90% |
| Buyback Yield | 0.02% |
| Shareholder Yield | 3.51% |
| Earnings Yield | 4.00% |
| FCF Yield | 4.70% |
Analyst Forecast
The average price target for Medtronic is $96.00, which is 21.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $96.00 |
| Price Target Difference | 21.40% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 4.55% |
| EPS Growth Forecast (5Y) | 18.93% |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.84 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.84 |
| Piotroski F-Score | 7 |